Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

EC approves Pfizer’s NSCLC drug Vizimpro

pharmaceutical-technologyApril 23, 2019

Tag: NSCLC , EC , Vizimpro , Pfizer

PharmaSources Customer Service